UCLA HF Guideline
CHARM demonstrated benefits of ARB in ACE intolerant patients as well as in patients on ACE inhibitors. Recommend use in patients that cannot tolerate or have unacceptable side effects with ACE inhibitors or as add on therapy to ACE inhibitor, beta blocker, and aldosterone antagonists, but not as first line therapy instead of ACE inhibitors. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.